Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

John M.H. de Klerk; Alfred D. van het Schip; Bernard A. Zonnenberg; Aalt van Dijk; Marcel P.M. Stokkel; Shiuw H. Han; Geert H. Blijham; Peter P. van Rijk

Research ArticleHuman Studies

Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham and Peter P. van Rijk

Journal of Nuclear Medicine September 1994, 35 (9) 1423-1428;

John M.H. de Klerk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfred D. van het Schip

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernard A. Zonnenberg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aalt van Dijk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel P.M. Stokkel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shiuw H. Han

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Geert H. Blijham

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter P. van Rijk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 35, Issue 9

September 1, 1994

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham, Peter P. van Rijk

Journal of Nuclear Medicine Sep 1994, 35 (9) 1423-1428;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham, Peter P. van Rijk

Journal of Nuclear Medicine Sep 1994, 35 (9) 1423-1428;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
The Placorhen Study: A Double-Blind, Placebo-Controlled, Randomized Radionuclide Study with 186Re-Etidronate in Hormone-Resistant Prostate Cancer Patients with Painful Bone Metastases
Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate
Rhenium-186-labeled Hydroxyethylidene Diphosphonate Dosimetry and Dosing Guidelines for the Palliation of Skeletal Metastases from Androgen-independent Prostate Cancer

Google Scholar

Main menu

User menu

Search

Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles